The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Gold nanoparticles in combinatorial cancer therapy strategies
Abstract
Cancer is one of the most important health issues, which is the second leading cause of death in the world. Conventional cancer therapy methods encounter with serious drawbacks and cannot often provide satisfactory outcomes. It has been demonstrated that the effect of various treatment modalities can be enhanced when combined with nanomaterials. Moreover, a new trend is being emerged in clinical oncology to shift from monotherapy toward combination therapy in the presence of useful nanomaterials. This way, the synergistic interactions occur among different treatments, which result in much stronger therapeutic effect than separate use of corresponding monotherapies. Recently, gold nanoparticles (AuNPs) have been widely implemented as one of the leading nanomaterials for combinatorial cancer therapy. In this review article, the importance and benefits of AuNPs in the field of combinatorial cancer therapy are firstly explained. Then, the applications of AuNPs in the most clinically established cancer therapy modalities, including chemotherapy, radiotherapy and a variety of hyperthermia methods will be described. Recent progresses in the application of AuNPs in dual- and triple-modality cancer therapies will be reviewed. Also, a brief summary of the role of AuNPs in photodynamic therapy and gene therapy will be provided. Finally, the opportunities and challenges of the entry of AuNPs into the clinics for use in cancer therapy methods are discussed. © 2019 Elsevier B.V.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
Multidrug resistance in cancer: role of ATP–dependent transporters
Gottesman, M. M., Fojo, T., & Bates, S. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc706 · Cited by 5,536
Cancer nanotechnology: opportunities and challenges
Ferrari, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1566 · Cited by 4,558
Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
Darby, S. C., Ewertz, M., McGale, P., Bennet, A. M., Blom-Goldman, U., Brønnum, D., Correa, C., Cutter, D., Gagliardi, G., Gigante, B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209825 · Cited by 3,974
Exploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Xia, Y. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201403036 · Cited by 2,164
Gold nanoparticles for applications in cancer radiotherapy: Mechanisms and recent advancements
Her, S., Jaffray, D. A., & Allen, C. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.12.012 · Cited by 865
Diagaradjane, P., Shetty, A., Wang, J. C., Elliott, A. M., Schwartz, J., Shentu, S., Park, H. C., Deorukhkar, A., Stafford, R. J., Cho, S. H., et al. (2008) · Nano Letters · doi:10.1021/nl080496z · Cited by 215
Hybrid nanoparticles for combination therapy of cancer
He, C., Lu, J., & Lin, W. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.09.029 · Cited by 174
Lammers, T., Peschke, P., Kühnlein, R., Subr, V., Ulbrich, K., Debus, J., Huber, P., Hennink, W., & Storm, G. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.10.032 · Cited by 124
Cited by
Gold nanoparticles: Synthesis properties and applications
Hammami, I., Alabdallah, N. M., jomaa, A. A., & kamoun, M. (2021) · Journal of King Saud University - Science · doi:10.1016/j.jksus.2021.101560 · Cited by 617
Applications and challenges of thermoplasmonics
Baffou, G., Cichos, F., & Quidant, R. (2020) · Nature Materials · doi:10.1038/s41563-020-0740-6 · Cited by 470
Recent Progress in Nanostructured Smart Drug Delivery Systems for Cancer Therapy: A Review
Khan, M. I., Hossain, M. I., Hossain, M. K., Rubel, M. H. K., Hossain, K. M., Mahfuz, A. M. U. B., & Anik, M. I. (2022) · ACS Applied Bio Materials · doi:10.1021/acsabm.2c00002 · Cited by 370
Recent advances of multi-dimensional porphyrin-based functional materials in photodynamic therapy
Tian, J., Huang, B., Nawaz, M. H., & Zhang, W. (2020) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2020.213410 · Cited by 369
Wang, G., Wu, W., Zhu, J.-J., & Peng, D. (2021) · Ultrasonics Sonochemistry · doi:10.1016/j.ultsonch.2021.105781 · Cited by 61
Metadata
- Authors
- Beik, J., Khateri, M., Khosravi, Z., Kamrava, S. K., Kooranifar, S., Ghaznavi, H., & Shakeri-Zadeh, A.
- Venue
- Coordination Chemistry Reviews
- Publisher
- Elsevier BV
- Published
- 2019-05
- Volume
- 387
- Pages
- 299-324
- ISSN
- 0010-8545 (ISSN-L)
- OpenAlex
- W2918604749
- Cited by
- 229
- References
- 13
- FWCI
- 11.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gold nanoparticles in combinatorial cancer therapy strategies. https://app.cochat.ai/papers/10.1016/j.ccr.2019.02.025
- The paper
- Beik, J., Khateri, M., Khosravi, Z., Kamrava, S. K., Kooranifar, S., Ghaznavi, H., & Shakeri-Zadeh, A. (2019). Gold nanoparticles in combinatorial cancer therapy strategies. Coordination Chemistry Reviews. https://doi.org/10.1016/j.ccr.2019.02.025
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.